Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsPharmaceutical Centrophenoxine
PharmaceuticalNootropicAntioxidantCholinergicDMAE ester

Centrophenoxine

Also known as Meclofenoxate · Lucidril · Centrophenoxine

An older cholinergic/antioxidant drug (a DMAE ester) marketed in some countries for age-related cognitive decline. Human data is mostly old and small; it is popular in anti-ageing nootropic circles.

01 Overview

Centrophenoxine (meclofenoxate) is an ester of DMAE and a chlorophenoxyacetic acid, developed in the 1950s. It has been used clinically in some European and Asian countries for senile dementia and age-related cognitive impairment, and is studied for its reported effect of reducing lipofuscin accumulation in neurons.

Most supporting studies are decades old and modest in size. It is available as a prescription drug in some jurisdictions and sold as a research chemical or supplement elsewhere.

02 Mechanism

Hydrolyses to DMAE, a putative acetylcholine precursor, plus an antioxidant moiety; reported to reduce age-related lipofuscin ('ageing pigment') in brain tissue.

03 Dosing

TierDoseRouteNotes
Common250–500 mg/dayOral
Therapeutic600–1000 mg/dayOralOlder trials used up to ~2000 mg/day divided.

04 Effects

EffectMagnitudeEvidence
Cognitive support in elderlyOlder small trials reported benefit in dementia; healthy-user data is lacking.ModestClinical
Antioxidant / anti-lipofuscin actionReduced lipofuscin accumulation in animal studies.Preclinical

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Overstimulation and insomniaThe DMAE component can cause restlessness, irritability or insomnia.MildUncommonAnecdotal
HeadacheHeadache at higher doses.MildUncommonAnecdotal

07 References

Meclofenoxate (centrophenoxine) in cognitive impairmentClinical geriatric literature

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.